CDWCDW Corporation
- Headquarters
- Vernon Hills, IL
- CEO
- Christine A. Leahy
- Next results
- around Feb 3, 2027
What CDW's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Sona Chawla Chief Growth and Innovation Officer |
Adopted 10b5-1 plan | Feb 29, 2024 | up to 51,828 | 274 days | 10-Q May 1, 2024 |
The company's descriptionOn February 29, 2024, Sona Chawla, Chief Growth and Innovation Officer of the Company, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. Ms. Chawla’s plan provides for the exercise of stock options and sale of up to an aggregate of 51,828 underlying shares of common stock of the Company during the period from May 30, 2024 through February 28, 2025. | |||||
| Christina Corley Chief Commercial and Operating Officer |
Ended other arrangement | Aug 22, 2023 | up to 83,099 | 275 days | 10-Q Nov 1, 2023 |
| Christine Leahy Chair, President, and Chief Executive Officer |
Adopted 10b5-1 plan | Aug 7, 2023 | up to 51,437 | 167 days | 10-K Feb 26, 2024 |
The company's descriptionOn August 7, 2023, Christine Leahy, Chair, President, and Chief Executive Officer of the Company, adopted a Rule 10b5-1 trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This plan provides for the exercise of stock options and sale of up to an aggregate of 51,437 underlying shares of common stock of the Company during the period from November 15, 2023 through April 30, 2024 | |||||
| Christine Leahy Chair, President and Chief Executive Officer |
Ended 10b5-1 plan | May 3, 2023 | up to 51,437 | 76 days | 10-Q Aug 2, 2023 |
The company's descriptionOn May 3, 2023, Christine Leahy, Chair, President and Chief Executive Officer of the Company, terminated a Rule 10b5-1 trading plan adopted on February 16, 2023 for the sale of stock options covering up to an aggregate of 51,437 shares of common stock of the Company, effective immediately. No shares were sold under the trading plan. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.
Form 144 notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | CONNELLY ELIZABETH H. Officer |
26,695 | $3,674,350 | Stock Option Exercise | none given | 26,695 shares from Aug 7, 2026 |
| Dec 8, 2025 | Chawla Sona Officer |
7,400 | $1,081,096 | Restricted Stock Vesting | none given | none found |
From the Form 144 XML filed with the SEC, since Dec 8, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on CDW in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CDW/export.csv") into a cell.